Harrow, Inc. SEC filings HROW
Harrow, Inc. has 868 filings in SEC EDGAR's recent list, going back to Jul 21, 2006. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 20, 2025 | — |
| 424B5 | Prospectus supplement | Jul 19, 2023 | — |
| 424B5 | Prospectus supplement | Jul 18, 2023 | — |
| 424B5 | Prospectus supplement | Dec 19, 2022 | — |
| FWP | Free writing prospectus | Dec 16, 2022 | — |
| 424B5 | Prospectus supplement | Dec 14, 2022 | — |
| 424B5 | Prospectus supplement | Dec 14, 2022 | — |
| S-3 | Shelf registration | May 26, 2022 | — |
| S-3 | Shelf registration | Sep 3, 2021 | — |
| S-8 | Employee stock plan registration | Jun 25, 2021 | — |
| 424B5 | Prospectus supplement | Jun 15, 2021 | — |
| FWP | Free writing prospectus | Jun 14, 2021 | — |
| 424B5 | Prospectus supplement | Jun 14, 2021 | — |
| 424B5 | Prospectus supplement | Apr 16, 2021 | — |
| FWP | Free writing prospectus | Apr 15, 2021 | — |
| 424B5 | Prospectus supplement | Apr 14, 2021 | — |
| S-3 | Shelf registration | Jul 2, 2020 | — |
| S-8 | Employee stock plan registration | Aug 25, 2017 | — |
| 424B5 | Prospectus supplement | Aug 25, 2017 | — |
| S-3/A | Filing | Jun 7, 2017 | — |
| S-3 | Shelf registration | May 26, 2017 | — |
| 424B5 | Prospectus supplement | Mar 22, 2017 | — |
| 424B3 | Prospectus | Jan 30, 2017 | — |
| S-3 | Shelf registration | Jan 23, 2017 | — |
| 424B5 | Prospectus supplement | Mar 14, 2016 | — |
| 424B5 | Prospectus supplement | Mar 14, 2016 | — |
| 424B5 | Prospectus supplement | Mar 10, 2016 | — |
| 424B5 | Prospectus supplement | Nov 27, 2015 | — |
| S-3/A | Amendment to form s-3 | Sep 19, 2014 | — |
| S-3 | Shelf registration | Sep 10, 2014 | — |
| S-8 | Employee stock plan registration | Sep 10, 2014 | — |
| 424B4 | Prospectus | Feb 11, 2013 | — |
| S-1MEF | S-1 registration statement | Feb 7, 2013 | — |
| S-1/A | Amended registration statement | Feb 4, 2013 | — |
| S-1/A | Amended registration statement | Nov 21, 2012 | — |
| S-1/A | Amended registration statement | Oct 26, 2012 | — |
| S-1/A | Amended registration statement | Sep 4, 2012 | — |
| S-8 | Employee stock plan registration | Aug 22, 2012 | — |
| S-1/A | Amended registration statement | Aug 16, 2012 | — |
| S-1 | Registration statement | Jul 25, 2012 | — |
| S-8 | Employee stock plan registration | May 12, 2009 | — |
| POS AM | Filing | May 7, 2009 | — |
| 424B3 | Prospectus | Mar 27, 2009 | — |
| 424B3 | Prospectus | Nov 20, 2008 | — |
| 424B3 | Prospectus | Aug 19, 2008 | — |
| 424B3 | Prospectus | May 29, 2008 | — |
| 424B3 | Prospectus | May 2, 2008 | — |
| 424B3 | Prospectus | Feb 22, 2008 | — |
| S-1/A | Amended registration statement | Feb 7, 2008 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HROW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Nashville, TN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1360214
- Former names
- HARROW HEALTH, INC. (until Sep 20, 2023); Imprimis Pharmaceuticals, Inc. (until Dec 17, 2018); TRANSDEL PHARMACEUTICALS INC (until Feb 27, 2012); Bywater Resources, Inc (until Sep 12, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.